By using a GLP-1 medication by itself , patients ended up with lower bone density after 1 year of treatment
Injecting into areas of lipodystrophy, scar tissue, or inflamed skin may result in erratic absorption and unpredictable drug levels
4 In a second meta-analysis study from 2019, which collected data from large-scale cardiovascular outcome trials, found that of the 56,004 patients on a GLP-1 agonist with type 2 diabetes, 180 experienced acute pancreatitis, and 108 cases of pancreatic cancer were reported
Six types of metabotherapy can be distinguished: supplements, stabilizers, and mimetics and/or agonists enhance beneficial effects, whereas production inhibitors, degraders and antagonists counteract detrimental effects